This study was undertaken to compare efficacy, tolerability, and pharmacokinetics of DM-1992, an extended-release formulation of carbidopa/levodopa (CD/L-dopa) with immediate-release (IR) CD/L-dopa in patients with advanced Parkinson’s disease.
Articles Collection
- This article collection was made possible by Cynapsus.
Footer
Copyright © 1999-2024 John Wiley & Sons, Inc. All Rights Reserved.
